Abou Dalle I, Galimard JE, Poire X, Sanz J, et al. The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations. Bone Marrow Transplant 2026;61:326-332.
PMID: 41437149